Skip to main content
OpenTrials
Completed

NCT Number: NCT02343237

Osteopathic Medicine in Fibromyalgia Syndrome

The purpose of this study is to evaluate the analgesic effects of a 6 weeks osteopathic treatment on patients with fibromyalgia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hotel-Dieu Hospital

Paris, Île-de-France Region, 75004, France

About this study

An osteopathic treatment could have a positive and durable effect on pain and quality of life on patients with fibromyalgia.

This technique, in addition to the standard treatment in a multidisciplinary care center, could be efficient by releasing muscle tension.

This is a 24 months multicenter (2 recruiting centers, 1 care center), randomized, and placebo-controlled study. The purpose is to evaluate the analgesic efficacy of a 6 weeks osteopathic treatment compared to a 6 week standard treatment on patients with fibromyalgia. It includes 6 osteopathic/standard sessions of 20 minutes (of one week apart), a follow-up at 3 months, 6 months and 12 months.

The primary aim of this study is to evaluate the pain after each osteopathic session, at the end of the 6 weeks treatment, and after each visit, judging by the patient's pain measured by a numeric scale (EVA).

The secondary aims of this study, based on clinical exams and questionnaires are to evaluate the quality of life, the patient activity and the sleep improvement after osteopathic treatment, and to investigate if osteopathic medicine improves fatigue, comorbidities, and decrease additional visits and medical investigations.

This study will also allow to identify the profile of the osteopathic treatment responders patients

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient Male or female aged at least of 18
  • Patient with fibromyalgia, according to the American College of Rheumatology (ACR) 1990 criteria, with a global level of pain of 50 over a 100 mm EVA scale
  • Patient suffering from fibromyalgia for over a year
  • Patient with stable medical/non medical treatment for at least 1 month before the recruitment
  • Patient referred to a medical center for a multidisciplinary approach
  • Patient who can be followed for at least 12 months after the end of the osteopathic sessions
  • Patient giving his informed consent to participate in the study
  • Patient affiliated to or beneficiary of social insurance

Exclusion criteria

  • Treatment by physical approach in progress or not older than 3 months : physiotherapy, kinesitherapy, rehabilitation or manual treatment (osteopathic or chiropractic care, manual medicine)
  • Unability to attend 6 sessions, meaning one weekly session, of osteopathy, at Hôtel Dieu
  • Severe psychiatric pathology : major depression, psychosis
  • Pregnancy or breast feeding
  • The patient is already included in another clinical study
  • Patient under judicial protection

Treatment and study plan

Osteopathic treatment

Procedure

osteopathic sessions of 20 minutes

Factitious osteopathic treatment

Procedure

6 factitious osteopathic sessions of 20 minutes

Primary outcomes

  1. Evaluation of pain during the 6 weeks of osteopathic treatment

    Time frame: 6 weeks

    The assessment will be on the declarative of the patient. He will report every week the intensity of pain measured by a numeric scale (0 to 100).

Secondary outcomes

  1. Quality of life

    Time frame: 6 weeks after osteopathic treatment

    Questionnaires: Fibromyalgia Impact Questionnaire (FIQ) and SF-36 (Short Form health survey)

  2. Quality of life

    Time frame: 3 months after osteopathic treatment

    Questionnaires: FIQ and SF-36

  3. Quality of life

    Time frame: 6 months after osteopathic treatment

    Questionnaires: FIQ and SF-36

  4. Quality of life

    Time frame: 1 year after osteopathic treatment

    Questionnaires: FIQ and SF-36

  5. Fatigue

    Time frame: 6 weeks after osteopathic treatment

    Questionnaires: multidimensional fatigue inventory (MFI) scale

  6. Fatigue

    Time frame: 3 months after osteopathic treatment

    Questionnaires: MFI scale

  7. Fatigue

    Time frame: 6 months after osteopathic treatment

    Questionnaires: MFI scale

  8. Fatigue

    Time frame: 1 year after osteopathic treatment

    Questionnaires: MFI scale

  9. Pain

    Time frame: 6 weeks after osteopathic treatment

    Questionnaires: Brief Pain Inventory (BPI)

  10. Pain

    Time frame: 3 months after osteopathic treatment

    Questionnaires: BPI

  11. Pain

    Time frame: 6 months after osteopathic treatment

    Questionnaires: BPI

  12. Pain

    Time frame: 1 year after osteopathic treatment

    Questionnaires: BPI

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

  • URC-CIC Paris Descartes Necker Cochin

Registry information

Official study title

A Multicenter, Randomized Study, Against Credible Factitious Intervention That Evaluates the Interest of Osteopathic Medicine in the Management of Fibromyalgia Syndrome

Acronym: FIBROPATHIC

Important dates

Study start
2015
Primary completion
2017
Study completion
2018
First posted
Jan 21, 2015
Registry last updated
Sep 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.